BioPharma Credit said it expected to generate a 10% return on its investment into portfolio company, Novocure, and reported that its stake in Global Blood Therapeutics was set to increase. The company received a notice of prepayment from Novocure for its $150m loan. The company was expected to receive on or before 18 August 2020, approximately $154.8m, representing a return of 10.2%. Global Blood Therapeutics, meanwhile, said it would draw the second tranche of the term loan, in the amount of $75.0m, prior to 31 December 2020, which would increase the company's investment in GBT from $41.3m to $82.5m. At 8:36am: (LON:BPCR) Biopharma Credit Plc share price was -0.01p at 1.01p
Sign up to our
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
UK 350 Risers and Fallers
Tweets not available.